Have Tumor Suppressor PDCD4 and its Counteragent Oncogenic miR-21 Gone Rogue?
Molecular Interventions · 2010
DOI: 10.1124/mi.10.2.5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Interventions, 2010. Verfasst von Matthew R Young und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA. young-ma@mail.nih.gov. Hauptthemen laut MEDLINE: Gene Expression Regulation. Die Arbeit wurde bisher 46-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA. young-ma@mail.nih.gov
Zitieren
APA
Young, M. R., Santhanam, A. N., Yoshikawa, N., & Colburn, N. H. (2010). Have Tumor Suppressor PDCD4 and its Counteragent Oncogenic miR-21 Gone Rogue?. Molecular Interventions. https://doi.org/10.1124/mi.10.2.5
Vancouver
Young MR, Santhanam AN, Yoshikawa N, Colburn NH. Have Tumor Suppressor PDCD4 and its Counteragent Oncogenic miR-21 Gone Rogue?. Molecular Interventions. 2010. doi:10.1124/mi.10.2.5
BibTeX
@article{Young2010,
author = {Young, Matthew R and Santhanam, Arti N and Yoshikawa, Noriko and Colburn, Nancy H},
title = {Have Tumor Suppressor PDCD4 and its Counteragent Oncogenic miR-21 Gone Rogue?},
journal = {Molecular Interventions},
year = {2010},
doi = {10.1124/mi.10.2.5}
}
EUVIMED